Trial Profile
Pilot study of the efficacy and safety of quetiapine compared with valproate in the treatment of patients with bipolar disorder and rapid cycling: an open trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Valproic acid (Primary)
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 01 Oct 2008 Results published in Journal of Clinical Psychopharmacology.
- 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 29 Mar 2006 New trial record.